Format

Send to

Choose Destination
See comment in PubMed Commons below
Surg Infect (Larchmt). 2015 Dec;16(6):694-701. doi: 10.1089/sur.2015.098. Epub 2015 Sep 18.

Impact and Progression of Organ Dysfunction in Patients with Necrotizing Soft Tissue Infections: A Multicenter Study.

Author information

  • 11 Department of Surgery, University of Washington , Seattle, Washington.
  • 22 Department of Surgery, Vanderbilt University Medical Center , Nashville, Tennessee.
  • 33 Department of Surgery, University of Kentucky Healthcare , Lexington, Kentucky.
  • 44 Department of Surgery, The University of Texas Health Sciences at San Antonio , San Antonio, Texas.
  • 55 Department of Surgery, The Ohio State University , Columbus, Ohio.
  • 66 Department of Surgery, University of Maryland , Baltimore, Maryland.
  • 77 Department of Surgery, University of Missouri , Columbia, Missouri.
  • 88 Department of Surgery, University of California , San Diego, California.
  • 99 Department of Surgery, Maricopa Integrated Health Systems , Phoenix, Arizona.
  • 1010 Department of Surgery, Virginia Commonwealth University , Richmond, Virginia.
  • 1111 Department of Surgery, University of Virginia , Charlottesville, Virginia.
  • 1212 Department of Critical Care, University of Pittsburgh , Pittsburgh, Pennsylvania.
  • 1313 Department of Surgery, Yale University , New Haven, Connecticut.
  • 1414 Biomedical Statistical Consulting , [city], Pennsylvania.
  • 1515 Department of &&&City of Hope, Duarte, California.
  • 1616 AtoxBio Ltd. , Ness Ziona Israel .

Abstract

BACKGROUND:

Necrotizing soft tissue infections (NSTI) represent a rare but devastating disease for which the systemic manifestations have been poorly characterized. In an effort to define an optimal endpoint for clinical trials in this condition, the objective of this study was to establish the pattern of organ dysfunction over time and determine the correlation between organ dysfunction and clinical outcome in patients with NSTI.

METHODS:

We conducted a multicenter, retrospective clinical study of patients with NSTI presenting to 12 academic medical centers in the U.S. during 2013. Patients with a diagnosis of NSTI confirmed by surgical findings were included. Organ dysfunction was assessed using a modified Sequential Organ Failure Assessment (SOFA) score (mSOFA: excluding liver) on admission and on hospital days 1, 2, 3, 7, 10, and 14. The presence of organ dysfunction on admission and resolution of organ dysfunction were correlated with clinical parameters, including intensive care unit (ICU)-free days (of 28 d), ventilator-free days, number of debridements, and mortality rate. The incidence of acute kidney injury (AKI) and recovery also were assessed.

RESULTS:

There were 198 patients enrolled, of whom 62% were male, the mean age was 51 years, and 40% had monomicrobial infections. The mean mSOFA score on admission was 2.4 ± 3.0, with 49% of the patients having a score ≥2 and 35% a score of ≥3. Patients typically demonstrated worsening of the mSOFA score over the first 24 h followed by gradual resolution. An mSOFA ≥3 at admission was associated with a significant decrease in ventilator-free days (mean 20.1 vs. 25.6 days; p < 0.001); ICU-free days (15.2 vs. 23.1, p < 0.001); more debridements (mean 2.3 vs. 2.0; p = 0.11); a higher mortality rate (15.9% vs. 3.1%; p = 0.003); and a higher rate of AKI (59.4 vs. 35.9%; p < 0.001). The persistence of organ dysfunction (mSOFA >1) among survivors at day 14 was associated with fewer ICU-free days (17.8 vs. 23.6; p < 0.001) and ventilator-free days (23.6 vs. 27; p = 0.001) and a lower recovery rate from AKI (38.7% vs. 81.3%; p < 0.001).

CONCLUSION:

Early development of systemic organ dysfunction in patients with NSTI is associated with higher morbidity and mortality rates. Failure of the resolution of organ dysfunction by day 14 forecasts a poor outcome. The mSOFA score may be a useful marker for patient selection for inclusion in interventional trials, and the resolution of organ dysfunction by day 14 may be an important clinical endpoint.

PMID:
26381131
DOI:
10.1089/sur.2015.098
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Mary Ann Liebert, Inc.
    Loading ...
    Support Center